Qualigen Therapeutics Inc (QLGN) saw an uptrend of 11.33% in the recent trading with $3.93 being its most recent. The current price level -79.32% lower than the highest price of $19.00 marked by the stock while trading over the past 52-weeks, whereas it is 37.89% higher than the lowest price of $2.85 the company dropped to over past 52-weeks. The latest news story on QLGN appeared in (Associated Press Finance) under the title “BC-Most Active Stocks” on Today.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 1.00 for the stock.
Qualigen Therapeutics Inc Earnings – What Happened With QLGN
Coming around sales and income figures on QLGN Stock Income Statement, public trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor.
Qualigen Therapeutics Inc – Insider Activity and Holdings
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 1.64 million. QLGN does have institutional investors; and they hold 0.53% of the stock.
Key Metrics forQLGN
The liquidity is a key characteristic of any stock and is the main point of focus of both short-term as well as long term investors before start trading into a stock. In recently reported quarter, Qualigen Therapeutics Inc has a debt to equity ratio of 0.00.
Technical Analysis of Qualigen Therapeutics Inc (NASDAQ:QLGN) stock
To comprehend better with the trade moves and investors’ behavior, exploring the short, medium and long term technical indicators along with average volume of a stock is an effective way to make use of. When looking into those indicators for Qualigen Therapeutics Inc (QLGN), we notice that the stock’s 20-day average volume is at 2,421,610 shares. Medium term indicators at an average of 50% are spotting the stock at Buy with its 50-day average volume of 974,858 shares. And to end with, QLGN’s 100-day average volume are 522,177 shares.
